Idiopathische Lungenfibrose – Epidemiologie, Ursachen und klinischer Verlauf
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pathology and Forensic Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00292-019-00747-x.pdf
Reference29 articles.
1. Araki T, Putman RK, Hatabu H et al (2016) Development and progression of interstitial lung abnormalities in the Framingham heart study. Am J Respir Crit Care Med 194:1514–1522
2. Depianto DJ, Chandriani S, Abbas AR et al (2015) Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis. Thorax 70:48–56
3. Diaz De Leon A, Cronkhite JT, Yilmaz C et al (2011) Subclinical lung disease, macrocytosis, and premature graying in kindreds with telomerase (TERT) mutations. Chest 140:753–763
4. Garcia-Sancho C, Buendia-Roldan I, Fernandez-Plata MR et al (2011) Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis. Respir Med 105:1902–1907
5. Hackett NR, Butler MW, Shaykhiev R et al (2012) RNA-Seq quantification of the human small airway epithelium transcriptome. BMC Genomics 13:82
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Role of telomere dysfunction and immune infiltration in idiopathic pulmonary fibrosis: new insights from bioinformatics analysis;Frontiers in Genetics;2024-09-13
2. Predicting biomarkers related to idiopathic pulmonary fibrosis: Robust ranking aggregation analysis and animal experiment verification;International Immunopharmacology;2024-09
3. Real-world safety and effectiveness of pirfenidone and nintedanib in the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis;European Journal of Clinical Pharmacology;2024-07-04
4. What has antifibrotic therapy changed for patients with idiopathic pulmonary fibrosis;Meditsinskiy sovet = Medical Council;2024-06-05
5. Unveiling the role of copper metabolism and STEAP2 in idiopathic pulmonary fibrosis molecular landscape;Journal of Cellular and Molecular Medicine;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3